查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1501241

生物活性蛋白质和胜肽的全球市场－全球产业分析、规模、占有率、成长、趋势、预测（2031）- 按起源、依应用、依地区

Bio Active Protein and Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 223 Pages | 商品交期: 2-5个工作天内

价格
简介目录

随着消费者越来越寻求营养和健康食品，全球生物活性蛋白和胜肽市场强劲扩张。由于人口结构的变化、消费者偏好的变化以及生产技术的进步，预计这种成长将在未来十年持续下去。

与人口老化相关的慢性疾病的增加促使消费者寻求更健康的饮食选择，包括生物活性蛋白质和胜肽。消费者对化妆品和个人护理品中这些营养素的偏好不断增加，进一步扩大了市场规模。随着全球可支配收入水准的上升和人均食品支出的增加，更多的消费者将能够购买优质的健康产品。

植物性成分，特别是源自大豆和豌豆的成分，越来越受欢迎，因为素食主义和出于健康、可持续发展和道德原因避免吃肉的趋势日益成长。植物蛋白通常比动物性蛋白质更便宜且更容易提取，这使其对製造商很有吸引力。

本报告考察了全球生物活性蛋白质和胜肽市场，并提供了市场概述，包括按原产地、应用、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第1章 执行摘要

第2章 市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎（COVID-19）影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第3章 2018-2031年全球生物活性蛋白与胜肽市场展望

  • 2018-2031年全球生物活性蛋白与胜肽市场展望（按产地、价值（十亿美元））
  • 2018-2031年全球生物活性蛋白和胜肽市场前景（依应用和价值（十亿美元））
  • 2018-2031年全球生物活性蛋白与胜肽市场前景（依地区、价值（十亿美元））

第4章 北美生物活性蛋白与胜肽市场展望，2018-2031

第5章 欧洲生物活性蛋白与胜肽市场展望，2018-2031

第6章 亚太地区生物活性蛋白与胜肽市场展望，2018-2031年

第7章 拉丁美洲生物活性蛋白与胜肽市场展望，2018-2031

第8章 中东和非洲生物活性蛋白和胜肽市场展望，2018-2031

第9章 竞争态势

  • 2024年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • BASF SE
    • Seagarden AS
    • ADM
    • Ingredia SA
    • Rousselot S.A.S.
    • Peptan
    • Kerry Group plc
    • CP Kelco
    • Omega Protein Corporation
    • E.I. Du Pont De Nemours

第10章 附录

简介目录

The global market for bioactive proteins and peptides is experiencing robust growth as consumers increasingly seek out nutritional and healthy food options. This growth is projected to continue over the coming decade, driven by a combination of demographic shifts, evolving consumer preferences, and advances in production technologies.

Factors Influencing Market Growth

Several key factors are propelling the demand for bioactive proteins and peptides:

  • Aging Population: The rise in chronic diseases associated with aging is leading consumers to seek out healthier dietary options that include bioactive proteins and peptides.
  • Health and Wellness Trends: There is an increasing consumer preference for these nutrients in the cosmetics and personal care sectors, further expanding the market reach.
  • Economic Factors: As disposable income levels rise globally, alongside an increase in per capita food expenditure, more consumers are able to afford premium health-oriented products.
  • Plant-Based Trends: Plant source ingredients, particularly from soy and pea, are becoming more popular due to the growing trend towards vegetarian and meat-free diets for health, sustainability, and ethical reasons. Plant-derived proteins are also typically less expensive and easier to extract than animal sources, making them attractive to manufacturers.

Challenges in the Market

Despite robust growth, manufacturers face certain challenges:

  • Regulatory Environment: Stringent regulations increase operational costs and affect the overall efficiency of production and distribution.
  • Supply Chain Complexity: Issues within the supply chain can also pose significant hurdles for players in this market.

Regional Market Insights

North America is currently the leader in the global bioactive proteins and peptides market, attributed to its high demand for sports and nutritional foods. The busy lifestyle and work culture in this region have increased the consumption of ready-to-eat and functional beverages, creating significant opportunities for market players. However, other regions, including Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan, and the Middle East & Africa, also show promising growth potential.

Market Trends

The trend towards plant-sourced bioactive proteins and peptides is particularly strong, with this segment expected to see substantial year-on-year growth throughout the forecast period. The increasing physiological benefits and consumer preference towards vegetarian food contribute to this trend. Among applications, while functional foods remain popular, functional beverages are anticipated to see higher traction and growth, reflecting consumer desires for convenient, health-enhancing products.

Key Players in the Market

Leading companies in the global bioactive protein and peptides market include Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd., E.I. Du Pont De Nemours and Company, Fonterra Co-operative Group Ltd., Royal DSM, and CHS Inc. These players are at the forefront of addressing consumer demands through innovation and are expanding their market presence through strategic initiatives and extensive research & development activities.

Market Segmentation

The market is segmented based on source and application, offering insights into consumer preferences and product functionality:

By Source

  • Plant Source
    • Cereals
    • Legumes

§ Soy Protein Concentrates

§ Soy Protein Isolates

§ Textured Soy Protein

    • Pseudo cereals
    • Brasssicaceae species
    • Others
  • Animal Source
    • Dairy products

§ Whey

§ Casein

§ Milk Protein Concentrate

    • Egg & Meat
    • Gelatin
    • Fish & Insects
    • Seafood

By Application

  • Functional Food
  • Functional Beverages
  • Dietary Supplements
  • Animal Nutrition
  • Personal Care
  • Others (Printing & Painting)

Table of Contents

1. Executive Summary

  • 1.1. Global Bio Active Protein and Peptides Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 3.1. Global Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Plant
      • 3.1.1.2. Animal
      • 3.1.1.3. Marine
  • 3.2. Global Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Functional Food
      • 3.2.1.2. Functional Beverages
      • 3.2.1.3. Dietary Supplements
      • 3.2.1.4. Animal Nutrition
      • 3.2.1.5. Personal Care
      • 3.2.1.6. Others (Printing & Painting)
  • 3.3. Global Bio Active Protein and Peptides Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 4.1. North America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Plant
      • 4.1.1.2. Animal
      • 4.1.1.3. Marine
  • 4.2. North America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Functional Food
      • 4.2.1.2. Functional Beverages
      • 4.2.1.3. Dietary Supplements
      • 4.2.1.4. Animal Nutrition
      • 4.2.1.5. Personal Care
      • 4.2.1.6. Others (Printing & Painting)
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 5.1. Europe Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Plant
      • 5.1.1.2. Animal
      • 5.1.1.3. Marine
  • 5.2. Europe Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Functional Food
      • 5.2.1.2. Functional Beverages
      • 5.2.1.3. Dietary Supplements
      • 5.2.1.4. Animal Nutrition
      • 5.2.1.5. Personal Care
      • 5.2.1.6. Others (Printing & Painting)
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Plant
      • 6.1.1.2. Animal
      • 6.1.1.3. Marine
  • 6.2. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Functional Food
      • 6.2.1.2. Functional Beverages
      • 6.2.1.3. Dietary Supplements
      • 6.2.1.4. Animal Nutrition
      • 6.2.1.5. Personal Care
      • 6.2.1.6. Others (Printing & Painting)
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 7.1. Latin America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Plant
      • 7.1.1.2. Animal
      • 7.1.1.3. Marine
  • 7.2. Latin America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Functional Food
      • 7.2.1.2. Functional Beverages
      • 7.2.1.3. Dietary Supplements
      • 7.2.1.4. Animal Nutrition
      • 7.2.1.5. Personal Care
      • 7.2.1.6. Others (Printing & Painting)
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Plant
      • 8.1.1.2. Animal
      • 8.1.1.3. Marine
  • 8.2. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Functional Food
      • 8.2.1.2. Functional Beverages
      • 8.2.1.3. Dietary Supplements
      • 8.2.1.4. Animal Nutrition
      • 8.2.1.5. Personal Care
      • 8.2.1.6. Others (Printing & Painting)
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2024
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. BASF SE
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Therapy Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Seagarden AS
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Therapy Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. ADM
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Therapy Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Ingredia SA
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Therapy Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Rousselot S.A.S.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Therapy Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Peptan
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Therapy Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Kerry Group plc
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Therapy Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. CP Kelco
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Therapy Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Omega Protein Corporation
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Therapy Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. E.I. Du Pont De Nemours
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Therapy Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations